Cargando…
Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
Due to the continuously mutating nature of the H3N2 virus, two aspects were considered when preparing the H3N2 microneedle vaccines: (1) rapid preparation and (2) cross-protection against multiple antigenic variants. Previous methods of measuring hemagglutinin (HA) content required the standard anti...
Autores principales: | Shin, Yura, Kim, Jeonghun, Seok, Jong Hyeon, Park, Heedo, Cha, Hye-Ran, Ko, Si Hwan, Lee, Jae Myun, Park, Man-Seong, Park, Jung-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287697/ https://www.ncbi.nlm.nih.gov/pubmed/35842468 http://dx.doi.org/10.1038/s41598-022-16365-2 |
Ejemplares similares
-
Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022) -
Safe Coated Microneedles with Reduced Puncture Occurrence after Administration
por: Jeong, Hye-Rin, et al.
Publicado: (2020) -
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
por: Park, Heedo, et al.
Publicado: (2022) -
Microneedle technologies
por: Choi, Seong-O, et al.
Publicado: (2021) -
Live Vaccinia Virus-Coated Microneedle Array Patches for Smallpox Vaccination and Stockpiling
por: Choi, In-Jeong, et al.
Publicado: (2021)